Medical School of Chinese People's Liberation Army, Chinese People's Liberation Army General Hospital, Beijing 100853, China.
Department of Traditional Chinese Medicine, Hainan Branch of Chinese People's Liberation Army General Hospital, Sanya, Hainan province 572013, China.
J Tradit Chin Med. 2019 Aug;39(4):559-565.
To study the anti-tumor effects of the extracts from Huangqi (Radix Astragali Mongolici) and Ezhu (Rhizoma Curcumae Phaeocaulis) on the growth of Lewis lung carcinoma (LLC) in a xenograft mouse model and to investigate the possible underlying mechanism.
LLC tumor-bearing C57BL/6 mice were treated with normal saline, cisplatin (2 mg/kg intraperitoneally every other day), or Huangqi (Radix Astragali Mongolici) and Ezhu (Rhizoma Curcumae Phaeocaulis) (1∶1, 2∶1, or 3∶1 ratio; 5 , 8 , or 11 g/kg crude drug intragastrically every day) for 15 d. Body weights and tumor volumes were measured every other day. Tumors were excised on day 15 and analyzed. Tumor microvessel density (MVD) was assessed by immunohistochemical staining of CD34; and expression of vascular endothelial cell growth factor (VEGF), the mitogen-activated protein kinases p38 mitogen-activated protein kinase (MAPK), extracellular signal-regulated kinases 1 and 2 (ERK1/2), and Jun N-terminal kinase (JNK) and their phosphorylated forms were assessed by Western blotting.
Treatment with cisplatin caused a significant loss of body weight compared with controls, whereas Huangqi (Radix Astragali Mongolici) and Ezhu (Rhizoma Curcumae Phaeocaulis) extract combinations had no effect. Extracts from Huangqi (Radix Astragali Mongolici) and Ezhu (Rhizoma Curcumae Phaeocaulis) significantly decreased tumor weight and tumor MVD compared with controls, and at the 3∶1 treatment group had similar efficacy to cisplatin in reducing MVD. Tumors from Huangqi (Radix Astragali Mongolici) and Ezhu (Rhizoma Curcumae Phaeocaulis) treatments also showed decreased p38 MAPK, p-p38 MAPK, ERK1/2, p-ERK1/2, JNK, and p-JNK expression compared with the control group (all P < 0.01). VEGF protein expression was significantly reduced in the 2∶1 and 3∶1 treatment groups compared with the control group (P < 0.01).
Extracts from Huangqi (Radix Astragali Mongolici) and Ezhu (Rhizoma Curcumae Phaeocaulis) hindered LLC growth in the xenograft mouse model, possibly via inhibition of the MAPK signaling pathway, VEGF production, and tumor angiogenesis.
研究黄芪(蒙古黄芪)和莪术(蓬莪术)提取物对荷 Lewis 肺癌(LLC)移植瘤小鼠模型肿瘤生长的抗肿瘤作用,并探讨其可能的作用机制。
将 LLC 荷瘤 C57BL/6 小鼠用生理盐水、顺铂(2 mg/kg,隔天腹腔注射)或黄芪(蒙古黄芪)和莪术(蓬莪术)提取物(1∶1、2∶1 或 3∶1 比例;5、8 或 11 g/kg 灌胃)治疗 15 d。每隔一天测量体重和肿瘤体积。第 15 天切除肿瘤并进行分析。通过 CD34 的免疫组织化学染色评估肿瘤微血管密度(MVD);通过 Western blot 评估血管内皮生长因子(VEGF)、丝裂原活化蛋白激酶 p38(MAPK)、细胞外信号调节激酶 1 和 2(ERK1/2)和 Jun N 端激酶(JNK)及其磷酸化形式的表达。
与对照组相比,顺铂治疗导致体重明显下降,而黄芪(蒙古黄芪)和莪术(蓬莪术)提取物组合无此作用。与对照组相比,黄芪(蒙古黄芪)和莪术(蓬莪术)提取物显著降低了肿瘤重量和肿瘤 MVD,而在 3∶1 治疗组中,其降低 MVD 的效果与顺铂相似。与对照组相比,黄芪(蒙古黄芪)和莪术(蓬莪术)治疗组的肿瘤 p38 MAPK、p-p38 MAPK、ERK1/2、p-ERK1/2、JNK 和 p-JNK 表达也明显降低(均 P < 0.01)。与对照组相比,2∶1 和 3∶1 治疗组的 VEGF 蛋白表达明显降低(P < 0.01)。
黄芪(蒙古黄芪)和莪术(蓬莪术)提取物抑制荷 Lewis 肺癌移植瘤小鼠模型中的 LLC 生长,可能是通过抑制 MAPK 信号通路、VEGF 产生和肿瘤血管生成。